Filtered By:
Source: Reviews in Cardiovascular Medicine

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 1627 results found since Jan 2013.

Advances in epigenetic regulation of vascular aging.
Authors: Jin J, Liu Y, Huang L, Tan H Abstract Vascular aging is a major risk factor and driver of agerelated cardiovascular diseases (CVD). Atherosclerosis, hypertension, and other CVD lead to vascular dysfunction that involves multiple pathological processes such as oxidative stress, endothelial dysfunction, inflammation, and autophagy. Epigenetics refers to genetic changes that occur when the DNA remains unchanged that include DNA methylation, histone modification, and non-coding RNA. It has been reported that epigenetics plays an effective regulatory role in CVD and affects cardiovascular repair function. Prese...
Source: Reviews in Cardiovascular Medicine - June 13, 2019 Category: Cardiology Tags: Rev Cardiovasc Med Source Type: research

Vascular Complications of Percutaneous Transradial Cardiac Catheterization.
Authors: Patwardhan M, Mehra S, Movahed A, Daggubati R Abstract The percutaneous transradial approach for coronary angiography and percutaneous coronary intervention is increasing in the United States. Although its vascular safety profile is better than the traditional femoral approach, it is important to learn about potential complications. In this article, we present two cases of vascular complications, namely, pseudoaneurysm and radial artery occlusion, after transradial cardiac catheterization, along with a review of the relevant literature. PMID: 27667385 [PubMed - as supplied by publisher]
Source: Reviews in Cardiovascular Medicine - September 28, 2016 Category: Cardiology Tags: Rev Cardiovasc Med Source Type: research

Update on coronary artery bioresorbable vascular scaffolds in percutaneous coronary revascularization
Rev Cardiovasc Med. 2021 Mar 30;22(1):137-145. doi: 10.31083/j.rcm.2021.01.225.ABSTRACTCoronary angioplasty was first introduced in 1977. From plain old balloon angioplasty to the introduction of bare metal stents in 1986 and dual antiplatelet therapy in 1992 to much more later on. Due to the unacceptable rate of stent restenosis, drug eluting stents (DES) were introduced in 2000. The first generation showed an increase in late stent thrombosis which led to the introduction of the second generation DES with biocompatible or biodegradable polymers and thinner platforms. However very late stent thrombosis and late restenosis...
Source: Reviews in Cardiovascular Medicine - April 1, 2021 Category: Cardiology Authors: Nagi Azzi Wassim Shatila Source Type: research